A Versatile Technique for the In Vivo Imaging of Human Tumor Xenografts Using Near-Infrared Fluorochrome-Conjugated Macromolecule Probes
暂无分享,去创建一个
H. Suemizu | Masato Nakamura | E. Sasaki | T. Itoh | K. Kawai | H. Hashimoto | T. Ogura | Y. Higuchi
[1] A. Vahrmeijer,et al. Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer , 2012, Journal of surgical oncology.
[2] U. Pastorino,et al. Patient-Derived Xenografts of Non Small Cell Lung Cancer: Resurgence of an Old Model for Investigation of Modern Concepts of Tailored Therapy and Cancer Stem Cells , 2012, Journal of biomedicine & biotechnology.
[3] Sharon Bloch,et al. Near-infrared molecular probes for in vivo imaging. , 2012, Current protocols in cytometry.
[4] Erlong Zhang,et al. A review of NIR dyes in cancer targeting and imaging. , 2011, Biomaterials.
[5] Kami Kim,et al. Bright and stable near infra-red fluorescent protein for in vivo imaging , 2011, Nature Biotechnology.
[6] M. Suematsu,et al. The reconstituted 'humanized liver' in TK-NOG mice is mature and functional. , 2011, Biochemical and biophysical research communications.
[7] Michael Z. Lin,et al. Autofluorescent proteins with excitation in the optical window for intravital imaging in mammals. , 2009, Chemistry & biology.
[8] Michael Z. Lin,et al. Mammalian Expression of Infrared Fluorescent Proteins Engineered from a Bacterial Phytochrome , 2009, Science.
[9] H. Maeda,et al. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[10] K. Machida,et al. Higher susceptibility of NOG mice to xenotransplanted tumors. , 2009, The Journal of toxicological sciences.
[11] H. Fujii,et al. Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma , 2008, British Journal of Cancer.
[12] Vasilis Ntziachristos,et al. Performance of the red-shifted fluorescent proteins in deep-tissue molecular imaging applications. , 2008, Journal of biomedical optics.
[13] H. Suemizu,et al. Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice. , 2008, International journal of oncology.
[14] H. Suemizu,et al. Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice. , 2007, International journal of oncology.
[15] Chun-Jung Chang,et al. The Immunization Site of Cytokine-Secreting Tumor Cell Vaccines Influences the Trafficking of Tumor-Specific T Lymphocytes and Antitumor Efficacy against Regional Tumors1 , 2004, The Journal of Immunology.
[16] Markus G. Manz,et al. Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice , 2004, Science.
[17] M. Bibby,et al. Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages. , 2004, European journal of cancer.
[18] B. Rice,et al. Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. , 2004, Molecular imaging.
[19] Meng Yang,et al. Chronologically-specific metastatic targeting of human pancreatic tumors in orthotopic models , 2004, Clinical and Experimental Metastasis.
[20] Robert M. Hoffman,et al. Orthotopic Metastatic Mouse Models for Anticancer Drug Discovery and Evaluation: a Bridge to the Clinic , 2004, Investigational New Drugs.
[21] H. Maeda,et al. Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting. , 2003, Clinical pharmacokinetics.
[22] Mamoru Ito,et al. NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. , 2002, Blood.
[23] H. Shimada,et al. Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[24] Y. Fukushima,et al. Growth stimulation of non-small cell lung cancer xenografts by granulocyte-macrophage colony-stimulating factor (GM-CSF). , 1998, European journal of cancer.
[25] J. D. Di Santo,et al. Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. , 1998, British journal of haematology.
[26] R. Rees,et al. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma. , 1997, British Journal of Cancer.
[27] F. Esteban,et al. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer. , 1991, Seminars in cancer biology.
[28] H. Maeda,et al. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.
[29] I. Fidler,et al. Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. , 1986, Cancer research.